Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PATH Stock Forecast 2026-2027
$10.41
Current Price
$5.57B
Market Cap
Buy 3
Hold 15
Sell 1
Wall St Analyst Ratings
Distance to PATH Price Targets
+63.3%
To High Target of $17.00
+29.1%
To Median Target of $13.44
+15.3%
To Low Target of $12.00
PATH Price Momentum
+2.9%
1 Week Change
-13.7%
1 Month Change
-0.4%
1 Year Change
-36.5%
Year-to-Date Change
-47.5%
From 52W High of $19.84
+12.2%
From 52W Low of $9.28
📊 TOP ANALYST CALLS
Did PATH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if UiPath is one of their latest high-conviction picks.
Latest PATH Stock Price Targets & Analyst Predictions
Based on our analysis of 29 Wall Street analysts, PATH has a neutral consensus with a median price target of $13.44 (ranging from $12.00 to $17.00). The overall analyst rating is Buy (6.4/10). Currently trading at $10.41, the median forecast implies a 29.1% upside. This outlook is supported by 3 Buy, 15 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Sanjit Singh at Morgan Stanley, projecting a 63.3% upside. Conversely, the most conservative target is provided by Brad Sills at B of A Securities, suggesting a 15.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PATH Analyst Ratings
3
Buy
15
Hold
1
Sell
PATH Price Target Range
Low
$12.00
Average
$13.44
High
$17.00
Current: $10.41
Latest PATH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PATH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 16, 2026 | BMO Capital | Keith Bachman | Market Perform | Maintains | $14.00 |
| Mar 12, 2026 | UBS | Radi Sultan | Neutral | Maintains | $13.00 |
| Mar 12, 2026 | DA Davidson | Lucky Schreiner | Neutral | Maintains | $13.00 |
| Mar 12, 2026 | TD Cowen | Bryan C. Bergin | Hold | Maintains | $13.00 |
| Mar 12, 2026 | Canaccord Genuity | Kingsley Crane | Buy | Maintains | $15.00 |
| Mar 12, 2026 | Needham | Scott Berg | Buy | Upgrade | $15.00 |
| Mar 12, 2026 | B of A Securities | Brad Sills | Underperform | Maintains | $12.00 |
| Mar 12, 2026 | Morgan Stanley | Sanjit Singh | Equal-Weight | Maintains | $17.00 |
| Mar 12, 2026 | Wells Fargo | Michael Turrin | Equal-Weight | Maintains | $13.00 |
| Mar 12, 2026 | Mizuho | Siti Panigrahi | Neutral | Maintains | $12.00 |
| Mar 12, 2026 | Truist Securities | Terry Tillman | Hold | Maintains | $12.00 |
| Jan 12, 2026 | Barclays | Raimo Lenschow | Equal-Weight | Maintains | $18.00 |
| Jan 5, 2026 | RBC Capital | Matthew Hedberg | Sector Perform | Maintains | $17.00 |
| Dec 10, 2025 | RBC Capital | Matthew Hedberg | Sector Perform | Maintains | $19.00 |
| Dec 9, 2025 | Morgan Stanley | Sanjit Singh | Equal-Weight | Maintains | $19.00 |
| Dec 5, 2025 | DA Davidson | Lucky Schreiner | Neutral | Maintains | $15.00 |
| Dec 4, 2025 | BMO Capital | Keith Bachman | Market Perform | Maintains | $17.00 |
| Dec 4, 2025 | Evercore ISI Group | Kirk Materne | In-Line | Maintains | $17.00 |
| Dec 4, 2025 | Mizuho | Siti Panigrahi | Neutral | Maintains | $15.00 |
| Dec 4, 2025 | Wells Fargo | Michael Turrin | Equal-Weight | Maintains | $14.00 |
Uipath Inc. (PATH) Competitors
The following stocks are similar to UiPath based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Uipath Inc. (PATH) Financial Data
Uipath Inc. has a market capitalization of $5.57B with a P/E ratio of 20.0x. The company generates $1.61B in trailing twelve-month revenue with a 17.5% profit margin.
Revenue growth is +13.6% quarter-over-quarter, while maintaining an operating margin of +16.7% and return on equity of +14.4%.
Valuation Metrics
Market Cap
$5.57B
Enterprise Value
$4.06B
P/E Ratio
20.0x
PEG Ratio
0.2x
Price/Sales
3.5x
Growth & Margins
Revenue Growth (YoY)
+13.6%
Gross Margin
+84.6%
Operating Margin
+16.7%
Net Margin
+17.5%
EPS Growth
+101.7%
Financial Health
Cash/Price Ratio
+27.0%
Current Ratio
2.5x
Debt/Equity
3.9x
ROE
+14.4%
ROA
+1.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Uipath Inc. (PATH) Business Model
About Uipath Inc.
What They Do
Providers of end-to-end automation solutions.
Business Model
The company generates revenue by offering its RPA and automation platform to enterprises, enabling them to automate tasks with software robots. Its services include various features like low-code interfaces, API integrations, and process mining that cater to different industry needs, providing a flexible and efficient solution for workflow optimization.
Additional Information
Founded in 2005 and headquartered in New York, UiPath serves multiple sectors, including finance, healthcare, and manufacturing. The platform supports robust security and governance for enterprise deployments, promoting rapid automation capabilities without the need for extensive infrastructure.
Company Information
Sector
Technology
Industry
Software - Infrastructure
Employees
3,981
CEO
Mr. Daniel Solomon Dines
Country
United States
IPO Year
2021
Website
www.uipath.comUipath Inc. (PATH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
UiPath (PATH) Stock Slides as Market Rises: Facts to Know Before You Trade
UiPath (PATH) closed at $10.41 in the latest trading session, marking a -1.89% move from the prior day.
Apr 17, 2026
By Zacks Equity Research
Tale of the Tape
UiPath Stock Slides 39% in Six Months: a Buying Opportunity or a Hold?
PATH's 39% slide resets expectations, but steady growth, rising margins and strong cash position keep the stock in hold territory amid demand uncertainty.
Apr 14, 2026
By Shuvra Shankar Dey
Analyst Blog
UiPath (PATH) Dips More Than Broader Market: What You Should Know
The latest trading day saw UiPath (PATH) settling at $9.35, representing a -5.99% change from its previous close.
Apr 10, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
UiPath (PATH) closed at $10.41, down 1.89% from the previous trading session.
Why It Matters
UiPath's stock decline may indicate underlying concerns about its performance or market sentiment, potentially affecting future growth prospects and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Software stocks are experiencing a sell-off as AI models grow in power.
Why It Matters
Rising AI capabilities may lead to increased competition and reduced margins for software companies, prompting investors to reassess stock valuations and growth prospects.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
PATH's stock fell 39%, prompting a reassessment of expectations. However, steady growth, increasing margins, and a strong cash position support a hold rating amid demand uncertainty.
Why It Matters
PATH's significant drop indicates reevaluated market confidence, yet its growth, improving margins, and solid cash reserves suggest resilience, making it a potential hold for cautious investors.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
UiPath is focusing on agentic AI solutions to address enterprise needs, aiming to convert pilot projects into scalable deployments for potential long-term growth.
Why It Matters
UiPath's focus on agentic AI solutions addresses a critical need in enterprises, potentially leading to scalable deployments and sustainable revenue growth, impacting future stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Premium offers Style Scores to help investors identify strong stocks suitable for value, growth, or momentum strategies.
Why It Matters
The Zacks Style Scores can enhance stock selection, potentially leading to better investment decisions and improved portfolio performance across different investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
UiPath launched two new offerings on AgentExchange, Salesforce's marketplace, enhancing its product lineup for the agentic era.
Why It Matters
UiPath's new offerings on AgentExchange could enhance its market presence and revenue potential, indicating growth and innovation in automation, which may attract investor interest.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About PATH Stock
What is Uipath Inc.'s (PATH) stock forecast for 2026?
Based on our analysis of 29 Wall Street analysts, Uipath Inc. (PATH) has a median price target of $13.44. The highest price target is $17.00 and the lowest is $12.00.
Is PATH stock a good investment in 2026?
According to current analyst ratings, PATH has 3 Buy ratings, 15 Hold ratings, and 1 Sell ratings. The stock is currently trading at $10.41. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PATH stock?
Wall Street analysts predict PATH stock could reach $13.44 in the next 12 months. This represents a 29.1% increase from the current price of $10.41. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Uipath Inc.'s business model?
The company generates revenue by offering its RPA and automation platform to enterprises, enabling them to automate tasks with software robots. Its services include various features like low-code interfaces, API integrations, and process mining that cater to different industry needs, providing a flexible and efficient solution for workflow optimization.
What is the highest forecasted price for PATH Uipath Inc.?
The highest price target for PATH is $17.00 from Sanjit Singh at Morgan Stanley, which represents a 63.3% increase from the current price of $10.41.
What is the lowest forecasted price for PATH Uipath Inc.?
The lowest price target for PATH is $12.00 from Brad Sills at B of A Securities, which represents a 15.3% increase from the current price of $10.41.
What is the overall PATH consensus from analysts for Uipath Inc.?
The overall analyst consensus for PATH is neutral. Out of 29 Wall Street analysts, 3 rate it as Buy, 15 as Hold, and 1 as Sell, with a median price target of $13.44.
How accurate are PATH stock price projections?
Stock price projections, including those for Uipath Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 3:37 AM UTC